A detailed history of Dark Forest Capital Management LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 23,041 shares of HROW stock, worth $642,152. This represents 0.03% of its overall portfolio holdings.

Number of Shares
23,041
Holding current value
$642,152
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$22.22 - $36.67 $511,971 - $844,913
23,041 New
23,041 $612,000
Q1 2023

May 12, 2023

BUY
$13.84 - $21.46 $40,855 - $63,349
2,952 New
2,952 $62,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $754M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.